Evaluation of an Oral Nutritional Supplement Containing AN777

Inclusion Criteria:

- Subject (male or female) is > or equal to 65 and < or equal to 90 years of age

Subject is ambulatory

Subject has a Subjective Global Assessment of B or C

Subject has gait speed <0.8 m/s AND/OR low hand-grip strength

Subject has Class 1 or Class 2 sarcopenia

Subject agrees to refrain from starting a resistance exercise program

Exclusion Criteria:

Subject has type 1 or type 2 diabetes

Subject has inflammatory disease with elevated high sensitivity C-reactive protein

Subject has renal function impairment

Subject reports gastrointestinal disorder (severe chronic diarrhea, nausea, vomiting) that
would preclude ingestion of the study product; an obstruction of the gastrointestinal
tract, inflammatory bowel disease; short bowel syndrome or other major gastrointestinal
disease

Subject reports of current active malignant disease or other significant medical
diagnoses.

Subject reports a history of allergy to any of the ingredients in the study products

Subject reports currently taking medications/dietary supplements/substances that could
profoundly modulate metabolism or weight.